The China Information Association of Traditional Chinese Medicine Established the Intelligent Decision-Making Sub-Association for the Comprehensive Evaluation of TCM

In order to build a technological source for the high-quality development of TCM, establish a diversified and efficient TCM service system, and gather new forces for the development of TCM, the founding ceremony and the first academic seminar of the Intelligent Decision-Making Sub-Association for the Comprehensive Evaluation of TCM, under the China Information Association of TCM, were successfully held in Beijing.

The former Deputy Director of the National Administration of TCM and President of the China Information Association for TCM, Wu Gang; former Deputy Director of the Administrative Service Bureau of the National Administration of TCM, Vice President, and Executive Secretary-General of the China Information Association of TCM, Zhu Jiaqing; the former Party Secretary and Director of the Beijing Food and Drug Administration, and President of the Beijing Pharmaceutical Society, Cong Luoluo; the former Party Secretary, Director, and Chief Researcher of Institute of Basic Clinical Medicine of the China Academy of Chinese Medical Sciences, Wang Yanping, as well as experts and scholars from various fields of the medical industry participated in the conference.

The founding ceremony and the first academic seminar of the Sub-association

The conference announced the list of the first board members, including the President, Vice Presidents, Secretary General, Deputy Secretary Generals, Executive Directors, and Directors. The association was officially inaugurated, and plaques and certificates were presented to its members.

Zhu Jiaqing announced the election results

Wu Gang delivered a speech

Wu Gang emphasized that the establishment of the Sub-Association marks a new starting point for the development of comprehensive evaluation and intelligent decision-making in TCM. It injects new vitality and momentum into the field of TCM comprehensive evaluation, which is of great significance. Using the association as a platform, developing a methodology system and intelligent decision-making tools for clinical comprehensive value assessment and transformation with TCM characteristics is a concrete action that responds to industry development needs and addresses industry “pain points”. It is also a practical step to enhance the service capabilities of TCM.

Liu Baoli stated that the Sub-association focuses on the development needs and technical challenges of the TCM industry. It is guided by clinical value and driven by innovation, carrying out in-depth research. At the same time, it will deeply integrate modern technological methods with TCM theory, promoting the digital and intelligent transformation of the TCM service system.

Liu Baoli gave an inaugural speech

Yi bowen pointed out that the greatest significance of the establishment of the branch lies in strengthening academic research and collaborative exchanges, and in constructing a scientific and systematic technical system for the comprehensive value assessment and transformation of TCM, as well as intelligent decision-making tools. This will provide more effective evidence support for government health policy formulation, clinical treatment plan optimization, and other multiple scenarios.

Yi bowen reported on the work plan of the branch

The founding conference was held alongside the first academic seminar. The seminar focused on the theme “Clinical Comprehensive Value Assessment and Transformation Technology and Methods in TCM”, inviting 12 authoritative experts and scholars from the industry to give keynote academic presentations. The seminar addressed industry hotspots, led academic frontiers, and engaged in in-depth discussions on new ideas, knowledge, and technologies related to clinical comprehensive value assessment and transformation technology in TCM, exploring feasible paths for promoting the construction of a high-quality TCM service system.

Lin Houwen gave a report titled “The Important Role of Clinical Pharmacy in Comprehensive Drug Evaluation and Clinical Value Positioning”

Shang Hongcai gave a report titled “Data Intelligence Empowerment of TCM Comprehensive Value Evaluation”

Zhang Huamin gave a report titled “From Selection to Regulation: Research and Practice of the Whole Life Cycle Comprehensive Evaluation System of Ancient Classic Prescription Formulations”

Tang Xudong gave a report titled “Difficult Gastrointestinal Diseases Prevention and Treatment: The Core Role of Efficacy Evaluation in Clinical Comprehensive Evaluation of Chinese Medicine and Its Practical Operation”

Wang Haifeng gave a report titled “Clinical Comprehensive Value Evaluation and Transformation Practice of Chinese Medicine: New Drug Development for COPD as a Demonstration”

Wu Jiarui gave a report titled “Innovations and Practices in Precision Evaluation of TCM Based on Integrated Big Data”

Zhao Yanhua gave a report titled “Research and Exploration on the Support of Medical Insurance Policies for the Development of TCM”

Shi Nannan gave a report titled “Technical Guidance Principles and Practices for Clinical Comprehensive Evaluation of Chinese Patent Medicine”

Yan Dan gave a report titled “New Technology for Comprehensive Clinical Efficacy Evaluation of Chinese and Western Medicine: Intelligent Construction of Disease Evolution Molecular Trajectories”

Jin Pengfei gave a report titled “Research on the Screening and Transformation of Illegal Additives in Chinese Medicine”

Tao Libo gave a report titled “Economic Evaluation of TCM and Its Decision-Making Applications”

Li Yifang gave a report titled “Clinical-Oriented Scientific Connotation Research on Heat-Clearing Chinese Medicines”

Liu Weijing hosted the academic seminar

Cultivating a fertile ground for the development of TCM and strengthening the support for its growth. In the future, the Branch will establish and improve the TCM standards system, promote the high-quality development of the TCM industry, fully stimulate the development potential of TCM, and explore the value of TCM inheritance and innovation. This will allow TCM to play a more prominent role in maintaining people’s health and preventing and treating diseases, striving to inject new vitality into the TCM cause in the context of the new era and open up broader development space.